Sanofi joins other diabetes drugmakers in cutting insulin prices
Bio Pharma Dive
MARCH 17, 2023
The pharma is the last of the three major insulin suppliers to reduce U.S. list prices, responding to persistent criticism and policy changes that will affect Medicaid rebate payments.
Let's personalize your content